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Abstract: Scales of shed king cobra (Ophiophagus hannah) skin from the dorsal portions, (SSS) and 
human breast epidermis (HE) were used as barrier membranes for comparison in an in vitro drug 
permeation study of nine active compounds (MW range 150-300 g mol
-1, pKa 3-10). Each compound, 
saturated in a donor solution at pH 4.0 or 5.6, permeated through the barrier membrane, fully hydrated. 
A  receptor  solution  at  pH  7.4  was  sampled  for  quantification  at  its  lmax  by  UV-Visible 
spectrophotometry and/or HPLC. The permeability coefficients of nine compounds were correlated to 
the n-octanol/water partition coefficients of these compounds. The permeability coefficient of these 
compounds using HE and SSS was correlated. Scales of shed skin from the dorsal portions of king 
cobras  were  shown  to  be  well  correlated  to  the  human  breast  epidermis  in  this  in  vitro  aqueous 
permeation study of these compounds. 
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INTRODUCTION 
 
  Permeation of drugs through the skin barrier has 
been  the  basis  of  transdermal  delivery
[1].  The  human 
skin  is  an  effective  and  selective  barrier  to  chemical 
permeation
[2]; however, it is not always possible to do 
actual  skin  permeation  studies  in  humans.  In  vitro 
permeation studies and model barrier membranes using 
excised skins (human cadaver and animals) or artificial 
materials have been employed. Animal skins generally 
gave  higher  permeation  profiles  than  the  human  skin 
because  of  the  differences  in  thickness,  stratum 
corneum,  density  of  hair  follicles,  sweat  glands  and 
appendages
[3]. The idea of using shed snake skin as the 
barrier  membrane  in  in  vitro  permeation  studies  was 
introduced  by  Higuchi  and  Kans
[4].  It  is  a  non-living 
tissue which can be obtained without sacrifices, lacks 
hair  follicles, and  gives less variation than  human or 
animal  skin.  Shed  skins  of  several  snakes,  such  as 
Elaphe  obsoleta
[3,5,6,7,8],  Python  reticulatus
[9]  and 
Ophiophagus  hannah
[10],  have  been  investigated.  
Haigh et al.
[7] emphasized the effect of species, sites 
and  regions  of  the  shed  snake  skin  used.  Good 
correlation of results to human skin suggested the use 
of  shed  snake  skin  as  a  model  membrane  for 
permeation studies despite the differences in anatomical 
and  chemical  compositions
[5,11,12].  Haigh  et  al.
[7] 
suggested that the differences  in  lipid  contents, a vital 
component of the skin, between shed snake and human 
skin could affect the permeability of compounds. 
  Shed  snake  skin  usually  consists  of  three 
distinctive  layers;  beta,  mesos  and  alpha-layers
[3]. 
Major  lipid  compositions  of  shed  snake  skins  are 
phospholipids  while  that  of  the  human  skin  are 
ceramides
[13]. Shed snake skin is composed of two very 
different  regions;  scales  and  separating  these,  hinges. 
The  scales  are  rigid  while  the  hinge  is  elastic.  The 
scales on the dorsal part are much smaller and usually 
thinner than the scales on the ventral part. Most of the 
studies related to the use of shed snake skins employed 
whole  skin  which  included  the  scales  and  hinges, 
except  that  of  Harada  et  al.
[9]  which  used  only  the 
scales of Python reticulatus for in vitro permeability of 
salicylic acid.  
  Factors  affecting  the  permeation  of  different 
compounds  include  ionization
[14],  partition,  and 
molecular weight
[14]. Takahashi et al.
[6] used six basic 
compounds  with  low  pKa  (0.6-5.3)  and  found  that             
non-ionized  forms  permeated  at  a  greater  rate                        
(0.01-33.3×10
-3 cm h
-1). Potts and Guy
[15] selected more 
than  90  compounds  from  various  reports  with 
molecular  weights  ranging  from  18  to  750  and                        
n-octanol/water partition coefficients (log Ko/w) ranging 
from ￿3 to 6 to predict skin permeability using multiple 
linear regressions. Am. J. Agril. & Biol. Sci.,  3 (2): 444-450, 2008 
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  In this study, weak acidic compounds and/or some 
of  their  salt  forms,  with  molecular  weights  ranging 
from 150 to 300 and  with different degrees of  water 
solubility  and  partition  coefficients,  were  selected  to 
compare the permeabilities through scales of the shed 
king cobra skin (SSS) and human epidermis (HE). Each 
compound permeated from a saturated donor solution at 
the skin pH of 4.0 (for salicylic acid) or 5.6 (for the 
others)  into  a  receptor  phase  containing  phosphate 
solution, pH 7.4 representing subdermal conditions. To 
evaluate  the  possibility  of  SSS  as  a  model  barrier 
membrane,  permeation  of  these  model  compounds 
across SSS and HE were compared.  
 
MATERIALS AND METHODS 
 
Materials: Methyl Paraben (MP) was purchased from 
Fluka (Buchs, Switzerland); Propyl Paraben (PP), Butyl 
Paraben  (BP),  Diclofenac  Sodium  (DS),  ibuprofen 
(Ibu),  Paracetamol  (Para)  and  Methyl  Salicylate 
(MeSA)  from  Sigma￿Aldrich  (Steinheim,  Germany); 
Salicylic Acid (SA) from Ajax Finechem (Seven Hills, 
Australia);  sodium  salicylate  (NaSA),  n-octanol  and 
methanol  (HPLC  grade)  from  BDH  Laboratory 
Supplies  (Poole,  England).  Other  reagents  used  were 
analytical grade and used as received.  
 
Apparatus:  Side-by-side  diffusion  cells,  with  an 
effective area of 0.694 cm
2 and a capacity volume of 3 
ml  each  (Crown  Glass  Company  Inc.,  U.S.A.),  a 
microprocessor  thickness  gauge  (Minitest  600B  Typ 
1210306,  Cologne,  Germany),  UV-Vvisible 
spectrophotometer  (Shimadzu  UV1700;  Pharmaspec, 
Japan),  and  high  performance  liquid  chromatography 
(HPLC;  Agilent  1100  series,  Waldbronn,  Germany) 
were used in this study.  
 
Partition  coefficient  determination:  Partition 
coefficients  between  n-octanol  and  McIlvaine  citrate-
phosphate  buffer  solution  at  pH  5.6  (CPS)  were 
determined. A mixture of an equal volume of n-octanol 
and CPS was pre-equilibrated for at least 1 h at 32±1°C. 
A specified amount of each drug was dissolved in the 
pre-equilibrated  n-octanol  and  CPS  at  an  equal 
concentration of 50-100 µg/ml each. A volume of 5 ml 
each of the n-octanol and CPS was thoroughly mixed, 
then shaken to equilibrate at 32±1°C for 12 h. Samples 
from  both  n-octanol  and  CPS  were  analyzed 
spectrophotometrically  for  drug  contents.  Apparent 
partition coefficient between n-octanol and CPS of each 
compound was calculated, as follows: 
   
   (1) 
where: 
Ko/w   =  Partition coefficient. 
Co  =   Concentration of drug in n-octanol phase.  
Cw  =  Concentration of drug in CPS phase. 
 
Preparation  of  donor  suspension  and  solubility 
studies:  To  calculate  the  apparent  permeation 
parameters of each compound, the total solubility was 
determined  under  the  same  conditions  as  the 
permeation  studies  and  represented  by  Cd  for  the 
concentration of the donor solution. An excess amount 
of  each  compound  was  added  to  provide  an 
oversaturated solution in 30 ml CPS in a tightly-closed 
container.  The  suspension  was  stirred  overnight  at 
temperature of 32°C. Filtrated samples (0.45 mm Nylon 
filter; Whatman International Ltd., England) were then 
analyzed at their maximum wavelengths by using UV-
Visible  spectrophotometry.  Samples  of  the  saturated 
solutions were introduced into the donor compartments 
to determine permeation fluxes across SSS and HE.  
 
Sources  of  skins:  Human  Epidermis  (HE)  and  shed 
king cobra scale (SSS): Human skin was obtained after 
breast  plastic  surgery  in  Srinagarind  Hospital,  Khon 
Kaen University, Thailand. Each volunteer donated the 
skin by following the protocol approved by the Ethics 
Committee with a signed informed consent. The donors 
were non-smoking Asian females (n = 11). Immediately 
after  excision,  subcutaneous  fat  was  removed  with 
tweezers  and  surgical  scissors.  The  epidermis  of  the 
skin samples was gently separated from the underlying 
dermis  after  removal  of  subcutaneous  fat  and 
immersion in water at 60°C for 45 sec and then gently 
peeling  off  the  epidermis
[16].  The  resultant  epidermal 
sheets were thoroughly dried on a sheet of filter paper 
(no.1, Whatman International Ltd., England) and stored 
flat in aluminium foil at 4-8°C until use.  
  Shed  king  cobra  skins  (n  =  4)  were  collected  at 
Khok Sanga King Cobra Club, Khon Kaen, Thailand. 
Each sheet of the skin was cleaned prior to storage in a 
tightly-closed container at 0±1°C until use. Each scale 
of the dorsal skin with a diameter of larger than 1 cm 
was used for one experiment after overnight hydration 
in CPS at room temperature. One sheet of the shed king 
cobra  skin  gave  approximately  30-40  scales  for  the 
experiment.  
  Average thicknesses of HE and SSS, measured by 
using a microprocessor thickness gauge, were 24.0±3.0 
and 18.7±2.0 mm (n = 25), respectively. 
 
In  vitro  permeation  studies:  A  piece  of  hydrated 
barrier  membrane  was  mounted  between  the  two 
compartments of the side-by-side diffusion cells  with 
the outer membrane surface facing towards  the  donor
o
o / w
w
C K
C
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Table 1:  HPLC systems for the determination of the compounds  
     Wavelength  Approx.  
 Compounds  Mobile phase (volume ratio)  (nm)  retention time (min) 
MP  Methanol : 0.02M acetate buffer pH 4.0 (25 : 75)  256  13.0 
PP  Methanol : 0.02M acetate buffer pH 4.0 (25 : 75)  256  48.6 
BP  Methanol : 0.02M acetate buffer pH 4.0 (25 : 75)   256  9.2 
Para  Methanol : deionized (DI) water (80 : 20)   243  7.8 
Ibu  Methanol : 0.1% phosphoric acid in DI water (80 : 20)   225  8.0 
DS  Methanol : 0.1% phosphoric acid in DI water (75 : 25)   276  11.5 
SA  Acetonitrile : DI water (60 : 40)    295  3.0 
MeSA  Acetonitrile : DI water (60 : 40)   295  7.0 
NaSA  Isopropanol : 1% formic acid in 0.1M potassium hydrogen orthophosphate (34.2 : 65.8)    295  13.4 
 
compartment. The donor compartment was filled with 
3.0 mL of saturated (about 2-5 times more solute than 
the amount required  for saturation to ensure constant 
thermodynamic  activity  throughout  the  experiment) 
with each compound in CPS to keep the concentration 
of  the  compound  constant  at  its  solubility  limit.  The 
receptor  compartment  was  filled  with  3.0  mL  of 
Sørensen,  modified  phosphate  buffer  solution  pH  7.4 
(PBS). Both compartments were stirred at 600 rpm and 
temperature  controlled  at  32±0.1°C  by  water  jacket 
circulation. A sink condition was always maintained in 
the receptor compartment. Samples (2.7 ml) were taken 
from  the  receptor  compartment  and  immediately 
replaced  with  an  equal  volume  of  fresh  PBS.  UV-
Visible  spectrophotometry  was  used  to  quantify  the 
permeated  compounds,  except  for  diclofenac  sodium 
where HPLC was used due to the detection limit of UV-
Visible  spectrophotometry.  The  concentration  of  the 
compound  in  the  receptor  solution  was  corrected  for 
previous  sample  removal  and  cumulative  permeated 
amount (Q, mg cm
-2) calculated. 
 
Quantitative analysis  
UV-Visible  spectrophotometry:  The  lmax  of  each 
compound,  obtained  by  scanning  using  a  UV-Visible 
spectrophotometer,  was  as  follows:  methyl  paraben, 
propyl paraben and butyl paraben 256 nm, paracetamol 
243 nm, diclofenac sodium 276 nm, ibuprofen 225 nm, 
salicylic acid, methyl salicylate and sodium salicylate 
295  nm. 
  Standards of the compounds were freshly prepared 
at appropriate concentrations in the relevant solvents. 
Validations  were  performed  by  10  replicates  of  the 
standards of within-day and more than 3 replicates of 
between-days. Linear correlation (r
2³0.998) was used to 
obtain calibration curves for quantitative analysis. 
 
HPLC analysis: HPLC was used to check and ensure 
the  qualitative  analysis  of  the  permeated  compounds. 
The  systems  used  are  shown  in  Table  1.  The  HPLC 
systems used, shown in Table 1, employed a HIQ SIL 
C18 column (250 mm×4.6 mm i.d.), 20 ml injection loop 
volume and isocratic mobile phase with a flow rate of 
1.0 ml/min at ambient temperature. The mobile phase 
was  filtered  through  0.45  mm  nylon  membrane  filter 
(Millipore,  U.S.A.)  and  degassed  before  use. 
Quantification  of  the  compounds  was  carried  out  by 
integration  of  peak  area  compared  with  the  relevant 
standards.  Using  paired  t-test  to  compare  with                   
UV-spectrophotometry of the same samples, analysis of 
diclofenac sodium was the only compound which was 
found significant different which might be explained by 
the findings of Llinàs et al.
[17]. Therefore, the analysis 
of  permeated  diclofenac  sodium  in  our  study  was 
performed by HPLC. Standards for diclofenac sodium 
at 0.01 to 30 mg mL
-1 in PBS were used. 
 
Data  treatment  and  statistics:  Steady-state 
permeation profiles of the drugs, and solubility or Cd, 
were used to estimate permeation rate or flux (J) and 
permeability coefficient (P).  
  Linear  regression  was  used  to  analyze  the 
relationship between the cumulative permeation amount 
of each compound per unit surface area (M, mg cm
-2) 
and  time  (t,  h).  For  each  compound,  a  correlation 
coefficient  of  more  than  0.99  with  an  average  of  6 
replicates was used to determine its slope, i.e. steady-
state flux (J, mg cm
-2 h
-1) according to Fick’s first law as 
shown in Eq. 2 and also lag time (tL, h). The permeation 
coefficient (P, cm h
-1) was calculated by using Eq. 3, as 
follows: 
     (2) 
 
   
   (3) 
 
where: 
dM/dt  =  Amount  of  compound  permeated  at  time 
interval (h). 
S   =   Effective  diffusional  area  of  the  diffusion 
cells (cm
2). 
Cd  =  The concentration of each compound in the 
donor  solution  which  was  controlled  at  its 
saturation, i.e. solubility. 
D   =  Diffusion coefficient (cm
2 h
-1). 
h   =   Thickness of barrier membrane (cm). 
d
dM
J PC
Sdt
= =
o / w
Ph
D
K
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  Statistical analysis at a significant level of p<0.05 
was performed, as follows: comparison of UV-Visible 
spectrophotometric  and  HPLC  analysis  of  the  same 
compound  by  paired  t-test,  cumulative  permeated 
amounts across HE and SSS by Student’s t-test, and a 
relationship of P, Ko/w and MW of the compounds by 
multiple  linear  regression  (SPSS  program  for  MS 
Windows, release 11.5) at a significant level of 0.05. 
 
RESULTS AND DISCUSSION 
 
  Table  2  summarizes  some  physicochemical 
properties of the compounds used in this study which 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: Steady  state  permeation  profiles  of  methyl 
paraben,  propyl  paraben  and  butyl  paraben 
paraben through (a) SSS and (b) HE at 32°C. 
Each point represents the mean ± SD (n = 6). 
Lines are best fitted by linear regression analysis 
are a range of drugs  with  molecular weights  (MW)  of 
about  150-300  g  mol
-1,  Ko/w  about  0.2-10,000  and 
poorly    to  highly  soluble  and/or  ionized in   aqueous 
solutions. Steady-state permeation profiles of the nine 
compounds through SSS, (Fig. 1, 2, 3a) and HE (Fig. 1, 
2, 3b),   into     an     aqueous      receptor     resulted   in 
linear relationships over the sampling period of 24 h. 
 
Table 2: Physicochemical properties of the compounds used  
Compound  MW  (g mol
-1)  pKa  Cd
* (mg/ml)  log (Ko/w)
** 
MP  152.2  8.17
[25]  2.14±0.11  2.0±0.1 
PP  180.2  8.35
[25]  0.34±0.00   2.1±0.1 
BP  194.2  8.37
[25]  0.24±0.02  3.0±0.1 
MeSA  152.1  -  0.69±0.04  2.2±0.3 
SA  138.1  3.0
[26]  15.0±1.94  -0.5±0.0 
NaSA  160.1  3.0
[21]  682±61.8  -0.7±0.0 
Ibu  206.3  5.3
[9]  0.88±0.29  0.7±0.1 
DS  318.1  4.2
[9]  0.11±0.05  2.5±0.0 
Para  160.1  9.5
[26]  13.4±0.11  0.4±0.0 
* n = 6,
 ** n = 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: Steady  state  permeation  profiles  of  salicylic 
acid,  methyl  salicylate  and  sodium  salicylate 
through (a) SSS and (b) HE at 32°C. Each point 
represents the mean ± SD (n = 6). Lines are best 
fitted by linear regression analysis 
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Table 3: Mean flux, lag time, permeability coefficient and diffusion coefficient of the compounds permeated through scales of shed king cobra 
skin (SSS) and human epidermis (HE) (n = 6)  
  Mean flux  Lag time  Permeability coefficient   Diffusion coefficient 
  (m cm
-2 h
-1)  (h)  (´10
-3 cm h
-1)  (´10
-6 cm
2 h
-1) 
  -----------------------------------  ------------------------------  -------------------------------  ---------------------------------- 
Compound  HE  SS  HE  SSS  HE  SSS  HE  SSS 
MP  16360±7.15  7.96±1.96  0.65±0.04  0.74±0.48  7.76±3.34  3.72±0.92  0.14±0.06  0.07±0.02 
PP  7.00±1.80  5.05±1.02  0.72±0.11  0.70±0.61  20.49±5.27  14.78±2.99  0.30±0.08  0.21±0.05 
BP  14.90±4.75  7.40±0.72  0.66±0.16  0.62±0.17  62.41±19.87  31.01±3.00  0.12±0.044  0.06±0.01 
MeSA  85.49±16.00  99.30±13.99  0.26±0.54  0.00  124.55±23  144.65±0.203  1.36±0.26  1.58±0.32 
SA  43.23±7.73  28.43±5.17  0.92±0.28  1.51±0.65  2.88±0.58  1.89±1.62  15.39±3.10  10.12±1.84 
NaSA  105.62±1.33  96.17±20.22  0.50±1.08  4.20±3.16  0.15±0.03  0.14±0.00  1.28±0.28  1.17±0.17 
Ibu  10.82±3.99  5.04±1.22  0.21±0.34  0.01  12.29±4.01  5.37±1.38  4.34±1.42  2.02±0.49 
DS  0.53±0.19  0.40±0.04  3.54±0.64  5.57±0.61  4.96±1.28  3.76±0.43  0.03±0.01  0.02±0.15 
Para  0.69±0.29  1.01±0.29  0  0.19  0.05±0.02  0.08±0.02  0.04±0.02  0.06±0.02 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3:  Steady  state  permeation  profiles  of 
paracetamol, ibuprofen and diclofenac sodium 
through (a) SSS and (b) HE at 32°C. Each point 
represents  the  mean  ±  SD  (n  =  6).  Lines  are 
best fitted by linear regression analysis 
  Calculation  of  the  results  from  these  figures  and 
parameters from  Table 2  results  in  steady-state  mean 
fluxes,  lag  times,  permeability  coefficients  (P)  and 
diffusion  coefficients  (D)  of  each  compound  through 
SSS and HE, shown in Table 3.  
  Methyl  paraben  gave  a  higher  permeation  than 
propyl  paraben  and  butyl  paraben.  This  was  found 
when using both SSS and HE as shown in Fig.1a and b, 
respectively. As expected, an increase in the ester chain 
length of parabens decreased the permeation flux but 
increased  permeability  coefficient.  The  results  were 
similar to those conducted by using whole shed skin of 
Elaphe  obsoleta
[3,18]  and  comparable  to  the  results 
obtained by using the human skin
[19,20].  
  Comparison  of  permeation  profiles  of  methyl 
salicylate, salicylic acid and sodium salicylate through 
SSS and HE, were shown in Fig. 2a and b, respectively. 
Sodium  salicylate,  a  salt  form  with  a  pKa  of  3.0
[21], 
ionized  in  the  donor  solution  and  was  found  to 
permeate after an initial period of the lag time. Methyl 
salicylate, on the other hand, permeated at a higher rate 
than sodium salicylate and salicylic acid because of its 
hydrophobicity and high partition coefficient. The pH 
of the donor solution which was suspended by salicylic 
acid  was  4.0,  the  same  pH  that  reported  by  Harada 
etal.
[9]. At this pH, salicylic acid showed precipitation 
due to saturation in the donor, its concentration  used 
was 3 times higher than that of Harada et al.
[9], and as a 
result,  our  permeability  coefficient  was  also  3  times 
higher.  
  The  permeation  profiles  of  ibuprofen,  diclofenac 
sodium,  and  paracetamol  through  SSS  and  HE  are 
demonstrated  in  Fig.  3a  and  b,  respectively.  The 
permeability coefficient of paracetamol was lower than 
that of diclofenac sodium and ibuprofen due to higher 
aqueous solubility and lower partition coefficient.    
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Fig. 4: Relationship between Log P and Log K(o/w) at 
32±1°C  of  all  model  drugs  used.  (o)  scale  of 
shed  king  cobra  skin  (SSS)  and  (·)  human 
epidermis (HE) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5: Correlation between permeability of the model 
drugs  through  the  human  epidermis  (PHE)  and 
the scales of shed king cobra skin (PSSS) 
 
  The solubility of paracetamol in the donor phase 
was  higher  than  that  of  ibuprofen,  while  Ko/w  was 
lower, as shown in     Table    2.   In comparison with   
ibuprofen, paracetamol distributed in the donor phase 
rather  than  partitioned  through  the  barrier  membrane 
into  the  receptor  medium,  resulted  in  lower 
permeability coefficient and diffusion coefficient. This 
finding  was  different  from  that  reported  by  Bhatt 
et al.
[11] which employed a mixture of propylene glycol 
and  methanol as the donor solution of ibuprofen and 
paracetamol.  The  donor  concentrations  of  both 
compounds in this present study,     much   less     than    
those reported by Bhatt et al.
[11].  
  Diclofenac sodium with its high Ko/w and low Cd 
was  poorly  soluble  in  aqueous  solution  but  highly 
distributed  into    the    SSS.  Its  permeation  was,  thus, 
rather low and slow and its lag time was found to be 
approximately 4 h which is similar to that reported by 
Morimoto et al.
[22]. Additionally, when comparison to 
salicylic  acid,  diclofenac  sodium  permeated  much 
slower, similar to the results of Gabboun et al.
 [23].    
  Figure 4 displays a linear relationship between log 
(P) and log (Ko/w) of the compounds using SSS and HE 
as  the  barrier  membranes  with  correlation  coefficient 
(r
2) of 0.544 and 0.534, respectively. This suggests that 
the overall profiles followed Fick’s first law
[24]. Further 
analysis of the relationship of permeability and Ko/w and 
MW  by  multiple  regressions  could  display  by  these 
following equations:  
 
SSS: log P = (0.575)log Ko/w + (-0.066)log MW -3.046 
    (r
2 = 0.544)   (4) 
 
HE: log P = (0.611)log Ko/w + 0.336log MW  -3.863 
    (r
2 = 0.534)   (5) 
   
  Multiple  regression  analysis  of  both  indicate  no 
significant difference (p<0.1). Both SSS and HE gave 
similar  increase  in  permeability  coefficients  of  drugs 
and related to lipophilicity and MW.   
  Our findings demonstrated the similarity between 2 
different types of barrier membranes, HE and SSS, in 
the permeation of nine compounds which occurred by a 
zero order process in accordance with Fick’s first law. 
The correlation between permeability of the compounds 
across HE and SSS by a plot between PHE and PSSS, as 
shown in Fig. 5, gave a linear line with a slope = 0.9193 
and r
2 = 0.9036 
 
CONCLUSIONS 
 
  The dorsal scale of shed king cobra skin behaves as 
a barrier membrane in this series of in vitro permeation 
studies  using  nine  compounds  of  varying  molecular 
weights,  aqueous  solubility  and  Ko/w.  The  higher  the 
molecular  weights  of  the  compounds,  the  slower  the 
permeation  rate,  and  the  greater  the  partition 
coefficient,  the  greater  the  permeability  of  the 
compounds.  Drugs  with  molecular  weight  between  
150-320 g mol
-1 and Ko/w about 0.2-10,000 permeated 
through  HE  and  SSS  under  sink  conditions  from  the 
donor solution at pH 5.6 into receptor solution at pH 
7.4, mimicking percutaneous absorption. The scales of 
shed    king  cobra  gave  similar  results  to  the  human 
epidermis. Dorsal scales of king cobra can provide a 
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model  for  human  epidermis  and  permeability  of  the 
compounds studied gave good linear correlation. 
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